8441 results
-
List item
Human medicine European public assessment report (EPAR): Memantine Mylan (updated)
memantine, Alzheimer Disease
Date of authorisation: 22/04/2013, Generic, Revision: 4, Authorised -
List item
Human medicine European public assessment report (EPAR): Dukoral (updated)
cholera vaccine (inactivated, oral), Cholera Immunization
Date of authorisation: 28/04/2004, Revision: 12, Authorised -
List item
Human medicine European public assessment report (EPAR): Tremfya (updated)
guselkumab, Psoriasis
Date of authorisation: 10/11/2017, Additional monitoring, Revision: 1, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Letifend (updated)
canine leishmaniasis vaccine (recombinant protein), Dogs
Date of authorisation: 20/04/2016, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): Simponi (updated)
golimumab, Arthritis, Psoriatic Spondylitis, Ankylosing Colitis, Ulcerative Arthritis, Rheumatoid
Date of authorisation: 01/10/2009, Revision: 31, Authorised -
List item
Human medicine European public assessment report (EPAR): Ryzodeg (updated)
insulin degludec / insulin aspart, Diabetes Mellitus
Date of authorisation: 21/01/2013, Revision: 10, Authorised -
List item
Human medicine European public assessment report (EPAR): Nucala (updated)
mepolizumab, Asthma
Date of authorisation: 02/12/2015, Additional monitoring, Revision: 9, Authorised -
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
lenvatinib, Thyroid Neoplasms
Date of authorisation: 28/05/2015, Additional monitoring, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (updated)
efavirenz / emtricitabine / tenofovir disoproxil, HIV Infections
Date of authorisation: 17/07/2017, Additional monitoring, Generic, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Jinarc (updated)
tolvaptan, Polycystic Kidney, Autosomal Dominant
Date of authorisation: 27/05/2015, Additional monitoring, Revision: 9, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Nobivac LeuFel (updated)
Feline leukaemia vaccine (inactivated), Cats
Date of authorisation: 06/11/2017, Revision: 1, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Leucogen (updated)
Feline leukaemia vaccine (inactivated), Cats
Date of authorisation: 17/06/2009, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): Trevicta (previously Paliperidone Janssen) (updated)
paliperidone, Schizophrenia
Date of authorisation: 05/12/2014, Revision: 8, Authorised -
List item
Human medicine European public assessment report (EPAR): Kyprolis (updated)
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015, Additional monitoring, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Afinitor (updated)
everolimus, Carcinoma, Renal Cell Breast Neoplasms Pancreatic Neoplasms
Date of authorisation: 03/08/2009, Revision: 21, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR (updated)
bluetongue vaccine (inactivated) (multistrain:1-2 strains out of a set of 3), Sheep Cattle
Date of authorisation: 17/12/2010, Revision: 6, Authorised -
List item
Human medicine European public assessment report (EPAR): Blincyto (updated)
blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015, Additional monitoring, Revision: 8, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Leucofeligen FeLV/RCP (updated)
feline calicivirosis, feline viral rhinotrachieitis, feline infectious enteritis (feline panleucopenia) vaccine (live), feline leukaemia vaccine (inactivated), Cats
Date of authorisation: 25/06/2009, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): BeneFIX (updated)
nonacog alfa, Hemophilia B
Date of authorisation: 27/08/1997, Revision: 37, Authorised -
List item
Human medicine European public assessment report (EPAR): Xeplion (updated)
paliperidone, Schizophrenia
Date of authorisation: 04/03/2011, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Orkambi (updated)
lumacaftor / ivacaftor, Cystic Fibrosis
Date of authorisation: 19/11/2015, Additional monitoring, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Invega (updated)
paliperidone, Schizophrenia Psychotic Disorders
Date of authorisation: 25/06/2007, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Ivabradine Zentiva (updated)
ivabradine, Angina Pectoris Heart Failure
Date of authorisation: 11/11/2016, Generic, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Eylea (updated)
aflibercept, Wet Macular Degeneration Macular Edema Diabetes Complications
Date of authorisation: 22/11/2012, Additional monitoring, Revision: 15, Authorised -
List item
Human medicine European public assessment report (EPAR): Fasenra (updated)
benralizumab, Asthma
Date of authorisation: 08/01/2018, Additional monitoring, Revision: 2, Authorised